This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is a challenge often faced by focal firms that global source? A) lack of ... (Read 78 times)

cool

  • Hero Member
  • *****
  • Posts: 570
Which of the following is a challenge often faced by focal firms that global source?
 
  A) lack of influence over corporate growth
  B) domestic management of local distribution
  C) cost of traveling both domestically and abroad
  D) lower-than-expected cost savings

Question 2

The World Bank Group is an example of which of the following?
 
  A) factoring house
  B) government assistance program
  C) multilateral development bank
  D) commercial bank



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

kbennett34

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

Thank you soo much

Answer to Question 2

C




cool

  • Member
  • Posts: 570
Reply 2 on: Jul 7, 2018
Excellent


tuate

  • Member
  • Posts: 332
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Approximately 25% of all reported medication errors result from some kind of name confusion.

Did you know?

In 2006, a generic antinausea drug named ondansetron was approved. It is used to stop nausea and vomiting associated with surgery, chemotherapy, and radiation therapy.

For a complete list of videos, visit our video library